Serum phosphate level at initiation of dialysis is associated with all-cause mortality: a multicenter prospective cohort study. 2018

Akiko Owaki, and Daijo Inaguma, and Isao Aoyama, and Shinichiro Inaba, and Shigehisa Koide, and Eri Ito, and Kazuo Takahashi, and Hiroki Hayashi, and Midori Hasegawa, and Yukio Yuzawa, and
a Tosei General Hospital , Seto , Aichi , Japan.

BACKGROUND As glomerular filtration rate (GFR) decreases, serum phosphate level increases. Previous reports indicated that serum phosphate level was associated with mortality in patients on dialysis. However, few reports have examined the association using dialysis initiation as the baseline period. METHODS This was a multicenter prospective cohort analysis including 1492 patients. Patients were classified into four quartiles based on the serum phosphate level at dialysis initiation, with Q1 being the lowest and Q4 the highest. All-cause mortality after dialysis initiation was compared using the log-rank test. The propensity score represented the probability of being assigned to group Q1 or Q2-4. All-cause mortality was compared in propensity score-matched patients by using the log-rank test for Kaplan-Meier curves. All-cause mortality of Q1 was compared with that for Q2-4 using multivariate Cox proportional hazard regression analysis. All-cause mortality was also determined among stratified groups with or without use of phosphate binders. RESULTS Significant differences in cumulative survival rates were observed between the four groups (p < .001). After propensity score-matching, mortality was significantly higher in the Q1 group than the Q2-4 group (p = .046). All-cause mortality was significantly higher in the Q1 group after adjustment for history of CAD (hazard ratio [HR] = 0.76, 95% confidence interval [CI]: 0.58 - 1.00, p = .048). However, there was no significant difference between the two groups after adjustment for estimated GFR. CONCLUSIONS The serum phosphate level at the time of dialysis initiation was associated with all-cause mortality. However, the serum phosphate level was dependent on the renal function.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D005260 Female Females

Related Publications

Akiko Owaki, and Daijo Inaguma, and Isao Aoyama, and Shinichiro Inaba, and Shigehisa Koide, and Eri Ito, and Kazuo Takahashi, and Hiroki Hayashi, and Midori Hasegawa, and Yukio Yuzawa, and
April 2018, Clinical and experimental nephrology,
Akiko Owaki, and Daijo Inaguma, and Isao Aoyama, and Shinichiro Inaba, and Shigehisa Koide, and Eri Ito, and Kazuo Takahashi, and Hiroki Hayashi, and Midori Hasegawa, and Yukio Yuzawa, and
September 2023, Clinical and experimental nephrology,
Akiko Owaki, and Daijo Inaguma, and Isao Aoyama, and Shinichiro Inaba, and Shigehisa Koide, and Eri Ito, and Kazuo Takahashi, and Hiroki Hayashi, and Midori Hasegawa, and Yukio Yuzawa, and
January 2021, International journal of chronic obstructive pulmonary disease,
Akiko Owaki, and Daijo Inaguma, and Isao Aoyama, and Shinichiro Inaba, and Shigehisa Koide, and Eri Ito, and Kazuo Takahashi, and Hiroki Hayashi, and Midori Hasegawa, and Yukio Yuzawa, and
April 2018, BMC nephrology,
Akiko Owaki, and Daijo Inaguma, and Isao Aoyama, and Shinichiro Inaba, and Shigehisa Koide, and Eri Ito, and Kazuo Takahashi, and Hiroki Hayashi, and Midori Hasegawa, and Yukio Yuzawa, and
January 2013, American journal of nephrology,
Akiko Owaki, and Daijo Inaguma, and Isao Aoyama, and Shinichiro Inaba, and Shigehisa Koide, and Eri Ito, and Kazuo Takahashi, and Hiroki Hayashi, and Midori Hasegawa, and Yukio Yuzawa, and
March 2024, Annals of internal medicine,
Akiko Owaki, and Daijo Inaguma, and Isao Aoyama, and Shinichiro Inaba, and Shigehisa Koide, and Eri Ito, and Kazuo Takahashi, and Hiroki Hayashi, and Midori Hasegawa, and Yukio Yuzawa, and
February 2008, Clinical and experimental immunology,
Akiko Owaki, and Daijo Inaguma, and Isao Aoyama, and Shinichiro Inaba, and Shigehisa Koide, and Eri Ito, and Kazuo Takahashi, and Hiroki Hayashi, and Midori Hasegawa, and Yukio Yuzawa, and
October 2022, Kidney medicine,
Akiko Owaki, and Daijo Inaguma, and Isao Aoyama, and Shinichiro Inaba, and Shigehisa Koide, and Eri Ito, and Kazuo Takahashi, and Hiroki Hayashi, and Midori Hasegawa, and Yukio Yuzawa, and
April 2017, Clinical and experimental nephrology,
Akiko Owaki, and Daijo Inaguma, and Isao Aoyama, and Shinichiro Inaba, and Shigehisa Koide, and Eri Ito, and Kazuo Takahashi, and Hiroki Hayashi, and Midori Hasegawa, and Yukio Yuzawa, and
January 2017, PloS one,
Copied contents to your clipboard!